Fresenius Kabi
News
October 4, 2022
Fresenius Kabi Expands Contrast Agent Portfolio with Launch of Gadoterate Meglumine Injection, USP
read moreSeptember 13, 2022
Fresenius Kabi Selected to Exhibit the Ivenix Infusion System at Vizient Innovative Technology Exchange
read moreSeptember 6, 2022
Fresenius Kabi receives U.S. FDA approval for biosimilar Stimufend® (pegfilgrastim-fpgk)
read moreSeptember 4, 2022
Fresenius Kabi and AABB Celebrate 17th Annual Blood Collectors Week from September 4-10, 2022
read moreAugust 8, 2022
Fresenius Kabi, a Leader in Injectable Medicines, Introduces Data Matrix Barcodes on all Drugs as part of Companywide Commitment to Medication Safety
read moreAugust 1, 2022
Fresenius Kabi’s Biologic License Application for Biosimilar Candidate Tocilizumab Accepted for Review in the U.S.
read moreJuly 29, 2022
Fresenius Kabi Announces U.S. Availability of Cancer Therapeutic Thiotepa
read moreJuly 25, 2022
Fresenius Kabi Expands Ready-to-Administer Portfolio with Glycopyrrolate Injection, USP Simplist® Prefilled Syringe
read moreJuly 18, 2022
Fresenius Kabi Introduces Generic Iodixanol Contrast Media Agent
read moreJuly 12, 2022
Romidepsin for Injection Available from Fresenius Kabi
read more
- October 12 - 16, 2022
- |
- Orlando, FL Live & Virtual
NASPGHAN: 2022 North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Postgraduate Course and Annual Meeting
Rosen Shingle Creek Orlando, FL
- October 14 - 15, 2022
- |
- New York City, NY Live & Virtual
NCCN Annual Congress: Hematologic Malignancies-National Comprehensive Cancer Network
New York Marriott Marquis
- October 17, 2022
- |
- Dallas, TX
Vizient Technology Exchange Conference
Renaissance Dallas Hotel Dallas, TX
- October 17 - 19, 2022
- |
- Kansas city, MO Live & Virtual
Cerner Health Conference
Kansas City Convention Center
- October 21 - 26, 2022
- |
- Charlotte, NC
ACG: American College of Gastroenterology 2022
Charlotte Convention Center Charlotte, NC
